查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1496879

全球椎體成形術和椎體後凸成形術市場 - 2024-2031

Global Vertebroplasty and Kyphoplasty Market - 2024-2031
出版日期: | 出版商: DataM Intelligence | 英文 182 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場動態

司機

骨質疏鬆症和脊椎疾病的發生率上升

全球椎體成形術和椎體後凸成形術市場的需求是由多種因素所驅動的。骨質疏鬆症是美國普遍存在的公共衛生問題。美國衛生局局長最近向美國人介紹了骨質疏鬆症的重要性，廣泛的研究表明，椎體壓迫性骨折是骨質疏鬆症最常見的併發症之一。

白人女性終生罹患骨質疏鬆性脊椎骨折的風險為 15.6%。美國每年診斷出超過 70 萬起繼發於骨質疏鬆症的椎體骨折，導致 11.5 萬人入院治療。骨質疏鬆性壓迫性骨折的主要後果是背痛、脊椎後凸和身高下降。

此外，該行業的主要參與者推出新產品和技術將推動該市場的成長。例如，2023 年 10 月，荷蘭公司 Amber Implants 開始開發用於脊椎損傷的下一代植入物，開始對其 VCFix 脊椎系統進行臨床試驗。該植入物旨在透過椎弓根錨定來最佳化脊椎中的負荷分佈。

首次人體試驗將評估 VCFix 對椎骨壓迫性骨折患者的安全性和有效性。它還包含一次性無菌手術套件，以確保可追溯性並降低感染風險。

此外，2021年8月，IZI Medical正式推出Vertefix HV Cement，該產品旨在解決椎體成形術和椎體後凸成形術中水泥注射過程中即時流量可視化的需求。

限制

與治療相關的高成本、嚴格的監管框架、與手術相關的併發症、缺乏熟練的專業人員以及有限的報銷政策等因素預計將阻礙市場。

有關此報告的更多詳細資訊 - 索取樣本

目錄

第 1 章：方法與範圍

  • 研究方法論
  • 報告的研究目的和範圍

第 2 章：定義與概述

第 3 章：執行摘要

  • 按設備類型分類的片段
  • 按應用程式片段
  • 最終使用者的片段
  • 按地區分類的片段

第 4 章：動力學

  • 影響因素
    • 促進要素
      • 骨質疏鬆症和脊椎疾病的發生率上升
      • 微創手術的採用率上升
      • 老年人口的增加
      • 醫療保健技術進步
    • 限制
      • 與治療相關的高成本
      • 缺乏熟練的專業人員
    • 機會
    • 影響分析

第 5 章：產業分析

  • 波特五力分析
  • 供應鏈分析
  • 定價分析
  • 監管分析
  • 未滿足的需求
  • PESTEL分析
  • 專利分析
  • SWOT分析

第 6 章：COVID-19 分析

  • COVID-19 分析
    • 新冠疫情爆發前的情景
    • 新冠疫情期間的情景
    • 新冠疫情後的情景
  • COVID-19 期間的定價動態
  • 供需譜
  • 疫情期間政府與市場相關的舉措
  • 製造商策略舉措
  • 結論

第 7 章：按裝置類型

  • 椎體成形裝置
    • 針
    • 水泥攪拌及輸送裝置
    • X光裝置
  • 椎體後凸成形術裝置
    • 針
    • 氣球
    • X光裝置

第 8 章：按申請

  • 外傷性椎骨骨折
  • 骨質疏鬆性椎骨骨折

第 9 章：最終用戶

  • 醫院
  • 門診手術中心
  • 專科診所

第 10 章：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 中東和非洲

第 11 章：競爭格局

  • 競爭場景
  • 市場定位/佔有率分析
  • 併購分析

第 12 章：公司簡介

  • Medtronic
    • 公司簡介
    • 產品組合和描述
    • 財務概覽
    • 主要進展
  • Jayon Implants
  • Johnson & Johnson
  • Joimax
  • Teknimed
  • Globus Medical
  • Stryker
  • MEDAID Inc
  • Biopsybell
  • Merit Medical Systems

第 13 章：附錄

簡介目錄
Product Code: MD1543

Overview

The global vertebroplasty and kyphoplasty market reached US$ 1.2 billion in 2023 and is expected to reach US$ 1.7 billion by 2031, growing at a CAGR of 5% during the forecast period 2024-2031.

Vertebroplasty and kyphoplasty are relatively new techniques for the treatment of pain caused by vertebral body compression fractures and stabilize the spine, thereby preventing further spinal dysfunction and improving quality of life.

Kyphoplasty differs from vertebroplasty in that a balloon is first inflated in the vertebral body to create a cavity into which cement is then injected under lower pressure. Kyphosis is a modern spine surgery procedure used to stabilize vertebral compression fractures caused by osteoporosis, cancer, and other conditions.

The market is driven by factors such as a rise in the adoption of minimally invasive surgeries, a rising incidence of osteoporosis & spinal disorders, an increase in the geriatric population, a rise in accidental cases, and technological advancements in healthcare.

Market Dynamics

Drivers

Rising Incidence of Osteoporosis & Spinal Disorders

The demand for the global vertebroplasty and kyphoplasty market is driven by multiple factors. Osteoporosis is a widespread public health problem in the United States. The surgeon general of the United States has recently introduced special attention to the importance of osteoporosis to Americans extensive study states that vertebral body compression fractures are among the most common complications of osteoporosis.

The lifetime risk of osteoporotic spine fracture in white women is 15.6%. Each year, more than 700,000 vertebral body fractures secondary to osteoporosis are diagnosed in the United States, resulting in 115,000 hospital admissions. The major consequences of osteoporotic compression fractures are back pain, kyphosis, and height loss.

Moreover, major key players in the industry launching new products and technology would propel this market growth. For instance, in October 2023, Amber Implants, a Netherlands-based company developing next-gen implants for spinal injuries, began clinical trials for its VCFix spinal system. The implant seeks to optimize load distribution in the spine via pedicle anchorage.

The first-in-human trial will evaluate VCFix's safety and efficacy for patients with vertebral compression fractures. It's also included with a single-use, sterile surgical kit to ensure traceability and reduce infection risk.

Also, in August 2021, IZI Medical officially launched Vertefix HV Cement, a product which aims to address the need for real-time flow visualization during cement injection for vertebroplasty and kyphoplasty procedures.

Restraints

Factors such as the high cost associated with the treatment, stringent regulatory framework, complications associated with the procedures, lack of skilled professionals, and limited reimbursement policies are expected to hamper the market.

For more details on this report - Request for Sample

Segment Analysis

The global vertebroplasty and kyphoplasty market is segmented based on device type, application, end-user, and region.

The kyphoplasty device segment accounted for approximately 62.5% of the global vertebroplasty and kyphoplasty market share

The kyphoplasty segment is expected to hold the largest market share over the forecast period owing to the advantages that kyphoplasty provides over vertebroplasty, such as reduction in back pain, as well as restoration of vertebral body height, and a lower rate of cement extravasation. This is mainly done by placing balloons to gently elevate the fractured vertebrae in an attempt to return them to the correct position.

According to the study published in Frontiers in Surgery Journal in July 2022, the use of kyphoplasty for the clinical treatment of osteoporotic vertebral compression fractures, spinal metastatic tumors, hemangiomas, myelomas, and vertebral nonunion has increased with the global development of minimally invasive spinal surgery.

Therefore, the rising adoption of kyphoplasty procedures for the treatment of vertebral compression fractures and cancers will lead to increased adoption of kyphoplasty devices, expected to drive the segment's growth.

Geographical Analysis

North America accounted for approximately 42.3% of the global vertebroplasty and kyphoplasty market share

North America region is expected to hold the largest market share over the forecast period owing to factors such as better healthcare infrastructure, rising funding from the government, awareness among people and healthcare industry stakeholders about available technologies, and the high concentration of market players in the region.

For instance, in September 2022, RevBio was awarded a Phase I Small Business Innovation Research (SBIR) grant from the National Institutes of Health. With the help of this grant, the company will be able to develop Tetranite, a patented bone adhesive technology, for the treatment of vertebral compression fractures.

Therefore, such funding for the development of technologies in vertebral compression fractures is expected to drive market growth due to the increased launch and adoption of products in the market over the forecast period.

Furthermore, according to Osteoporosis Canada, 2022, more than 2.3 million Canadians are living with osteoporosis and at least 1 in 3 women and 1 in 5 men suffer from an osteoporotic fracture during their lifetime. Such a huge prevalence of osteoporosis in Canada is expected to increase the adoption of vertebroplasty and kyphoplasty procedures in the Canadian population, thereby leading to the rising adoption of vertebroplasty and kyphoplasty devices, driving the market growth.

COVID-19 Impact Analysis

The COVID-19 pandemic significantly impacted the global vertebroplasty and kyphoplasty market. Hospital admissions for patients other than COVID-19 and serious diseases were restricted to hospitals to avoid the spread of the virus.

For instance, according to the study published in SAGE Journals in April 2022, there have been noticeable changes in the hospital admissions of patients with vertebral compression fractures (VCF) compared to the period before the COVID-19 pandemic. Fewer patients visited the emergency department for VCF during the peak of the Covid-19 pandemic which represented a 44% decrease. Hence, COVID-19 affected the pace of the market at the beginning of the pandemic.

Market Segmentation

By Device Type

  • Vertebroplasty Device
    • Needle
    • Cement Mixing & Delivery Devices
    • X-ray Device
  • Kyphoplasty Device
    • Needle
    • Balloon
    • X-ray Device

By Application

  • Traumatic Vertebral Fractures
  • Osteoporotic Vertebral Fractures

By End-User

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Rest of Europe
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Middle East and Africa

Competitive Landscape

The major global players in the vertebroplasty and kyphoplasty market include Medtronic, Jayon Implants, Johnson & Johnson, Joimax, Teknimed, Globus Medical, Stryker, MEDAID Inc, Biopsybell, and Merit Medical Systems among others.

Key Developments

  • In August 2023, Safe Orthopaedics SAS reported results from a biomechanical study comparing its new surgical technique Sycamore a pedicle-anchored implant with standalone balloon kyphoplasty.
  • In October 2022, Halma announced the acquisition of IZI Medical Products, a leading designer, manufacturer, and distributor of medical devices used across a range of diagnostic and therapeutic procedures. IZI Medical Products offers vertebroplasty and kyphoplasty products such as DURO-JECT Bone Cement Injector Set, Vertefix HV High Viscosity Bone Cement, and Kiva VCF Treatment System, which further expands Halma's product portfolio.
  • In April 2022, Nanox announced FDA approval for HealthOST Device, an AI software monitoring vertebral compression fractures and low bone density, which are frequently associated with osteoporosis.
  • In February 2022, Enlife Solutions represented Tecres, an Italian company in Romania. The representation includes a spinal and cranial portfolio of Tecres, including a Mendec spine vertebroplasty kit for osteoporosis.

Why Purchase the Report?

  • To visualize the global vertebroplasty and kyphoplasty market segmentation based on device type, application, end-user, and region as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development
  • Excel data sheet with numerous data points of global vertebroplasty and kyphoplasty market level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping is available in excel consisting of key products of all the major players.

The global vertebroplasty and kyphoplasty market report would provide approximately 62 tables, 55 figures, and 182 Pages.

Target Audience 2024

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Device Type
  • 3.2. Snippet by Application
  • 3.3. Snippet by End-User
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rising Incidence of Osteoporosis & Spinal Disorders
      • 4.1.1.2. Rise in the Adoption of Minimally Invasive Surgeries
      • 4.1.1.3. Increase in the Geriatric Population
      • 4.1.1.4. Technological Advancements in Healthcare
    • 4.1.2. Restraints
      • 4.1.2.1. High Cost Associated with the Treatment
      • 4.1.2.2. Lack of Skilled Professionals
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Unmet Needs
  • 5.6. PESTEL Analysis
  • 5.7. Patent Analysis
  • 5.8. SWOT Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID
    • 6.1.2. Scenario During COVID
    • 6.1.3. Scenario Post COVID
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Device Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
    • 7.1.2. Market Attractiveness Index, By Device Type
  • 7.2. Vertebroplasty Device*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 7.2.3. Needle
    • 7.2.4. Cement Mixing & Delivery Devices
    • 7.2.5. X-ray Device
  • 7.3. Kyphoplasty Device
    • 7.3.1. Needle
    • 7.3.2. Balloon
    • 7.3.3. X-ray Device

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Traumatic Vertebral Fractures *
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Osteoporotic Vertebral Fractures

9. By End-User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.1.2. Market Attractiveness Index, By End-User
  • 9.2. Hospitals *
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Ambulatory Surgical Centers
  • 9.4. Specialty Clinics

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. UK
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. South Korea
      • 10.5.6.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. Medtronic *
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio & Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
  • 12.2. Jayon Implants
  • 12.3. Johnson & Johnson
  • 12.4. Joimax
  • 12.5. Teknimed
  • 12.6. Globus Medical
  • 12.7. Stryker
  • 12.8. MEDAID Inc
  • 12.9. Biopsybell
  • 12.10. Merit Medical Systems

LIST NOT EXHAUSTIVE

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us